Deals

Two businessmen pushing giant puzzle pieces together as the sun sets behind them

TegMine bags tech from OBI to help fuel ADC ambitions

TegMine has landed certain rights to OBI's ADC tech, advancing the efforts of former Stemcentrx scientists to treat cancer by targeting carbohydrates.

Nick Paul Taylor Jun 6, 2025 10:00am

Seyltx gains option to boost cough pipeline with 8 NeurOp drugs

Jun 5, 2025 10:40am

Cullinan's $700M pact for BCMA bispecific to pair with other TCE

Jun 5, 2025 4:38am

photo of a pair of binoculars perched on a rock aimed at the rising sun

Are Lilly, Novartis eyeing the PD-1xVEGF field? Execs weigh in

Jun 4, 2025 1:00pm

Glowing puzzle piece fitting into puzzle

Vividion secures clinical-stage WRN inhibitor from Roche

Jun 4, 2025 9:21am

BioAge inks option agreement for Chinese biotech's obesity asset

Jun 3, 2025 2:06pm